Literature DB >> 1612323

Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease.

N J Talley1, G M Kephart, T W McGovern, H A Carpenter, G J Gleich.   

Abstract

Degrees of eosinophil infiltration and eosinophil degranulation, as evidenced by localization of the eosinophil granule major basic protein (MBP), were compared in patients with eosinophilic gastroenteritis, patients with celiac disease, and healthy controls using a specific indirect immunofluorescence technique for the localization of MBP. Formalin-fixed, paraffin-embedded biopsy specimens from the mucosa of the stomach and small intestine of 11 patients with eosinophilic gastroenteritis, from the small intestine of 4 patients with celiac disease, and from the stomach and/or upper small intestine of 18 healthy asymptomatic volunteers were tested. Degrees of eosinophil infiltration and extracellular deposition of MBP were graded by two blinded observers; each section was given a score from 0 (nil) to 4 (marked). In the small bowel biopsy specimens, both eosinophil infiltration and extracellular MBP deposition scores were significantly greater in patients with eosinophilic gastroenteritis and in patients with celiac disease than in controls. In the gastric biopsy specimens, extracellular MBP deposition scores were significantly increased in patients with eosinophilic gastroenteritis compared with controls even though eosinophil infiltration scores did not differ significantly at this site. The results support the hypothesis that the eosinophil, through toxic cationic proteins such as MBP, plays a role in the pathogenesis of these diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612323     DOI: 10.1016/0016-5085(92)91106-e

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

1.  Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.

Authors:  G T Furuta; S J Ackerman; J Varga; A M Spiess; M Y Wang; B K Wershil
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Extracellular Eosinophil Granule Protein Deposition in Ringed Esophagus with Sparse Eosinophils.

Authors:  Kathryn A Peterson; William J Cobell; Frederic C Clayton; Chaya Krishnamurthy; Jian Ying; Leonard F Pease; Hedieh Saffari; Ann Georgelas; John Fang; Gerald J Gleich; Kristin M Leiferman
Journal:  Dig Dis Sci       Date:  2015-04-23       Impact factor: 3.199

3.  Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.

Authors:  S C Bischoff; J Grabowsky; M P Manns
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

4.  Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis.

Authors:  Gail M Kephart; Jeffrey A Alexander; Amindra S Arora; Yvonne Romero; Thomas C Smyrk; Nicholas J Talley; Hirohito Kita
Journal:  Am J Gastroenterol       Date:  2009-11-03       Impact factor: 10.864

5.  Diagnostic and therapeutic strategies for eosinophilic esophagitis.

Authors:  Asifa K Zaidi; Ahad Mussarat; Anil Mishra
Journal:  Clin Pract (Lond)       Date:  2014

6.  Eosinophilic ascites, an unusual presentation of eosinophilic gastroenteritis: A case report and review.

Authors:  Iryna S Hepburn; Subbaramiah Sridhar; Robert R Schade
Journal:  World J Gastrointest Pathophysiol       Date:  2010-12-15

Review 7.  Food allergies.

Authors:  Paula F G O'Leary; Fergus Shanahan
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 8.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10

9.  Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis (am j gastroenterol 2010;105:298-307).

Authors:  Yunju Jo
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

10.  Vascular endothelial growth factor (VEGF)--a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis.

Authors:  Yesuf Taha; Yngve Raab; Anders Larsson; Marie Carlson; Lars Lööf; Bengt Gerdin; Magnus Thörn
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.